Back to search

Article

Exploring the PET in vivo generator <sup>134</sup> Ce as a theranostic match for <sup>225</sup> Ac

2024-04-28

Abstract excerpt

<h4>Purpose</h4> The radionuclide pair cerium-134/lanthanum-134 ( 134 Ce/ 134 La) was recently proposed as a suitable diagnostic counterpart for the therapeutic alpha-emitter actinium-225 ( 225 Ac). The unique properties of 134 Ce offer perspectives for developing innovative in vivo investigations not possible with 225 Ac. In this work, 225 Ac- and 134 Ce-labeled tracers were directly compared using intern...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00637f67-3df9-56c1-91ea-88def42d6a64
DOI
10.1101/2024.04.25.591165
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the PET in vivo generator <sup>134</sup> Ce as a theranostic match for <sup>225</sup> AcDOI 10.1101/2024.04.25.591165
Suppression of tumor cell lactate-generating signaling pathways eradicates murine PTEN/p53-deficient aggressive-variant prostate cancer via macrophage phagocytosisSemantic proximity
From Hurdles to Breakthroughs: Building and Validating a PSMA-positive Triple-Negative Breast Cancer Mouse Model for Preclinical Targeted Radionuclide TherapySemantic proximity
Biodistribution-Driven Discovery Identifies a Glycosidase-Cleavable Linker to Reprogram RadiotheranosticsSemantic proximity
Dosimetry-Driven Alpha Emitter Selection for Radioligand Therapy: Is daughter translocation a significant safety concern?Semantic proximity
Feasibility and Safety of 68Ga-PSMA-11 PET/CT Using Cyclotron-Produced 68Ga in Patients with Prostate CancerSemantic proximity
Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)Semantic proximity
A New Labelling Method of <sup>99m</sup> Tc-PSMA-HBED-CCSemantic proximity
An Automated and Putatively Versatile Approach for Labeling Peptides with Fluorine-18 Using the FastlabTM Synthesizer; Exemplified with Glu-the CO-Lys PharmacophoreSemantic proximity
Dose Escalation Biodistribution, Positron Emission Tomography/Computed Tomography Imaging and Dosimetry of a Highly Specific Radionuclide-labeled Non-blocking NanobodySemantic proximity
18F-AlF-FAPI nanotracer visualized the quick response of sarcoma to radiotherapy by PET/CTSemantic proximity
The Radiolabeling of [161Tb]-PSMA-617 by a Novel Radiolabeling Method and Preclinical Evaluation by In Vitro/In Vivo Methods.Semantic proximity
Advantage of the F(ab)’2 fragment over IgG for RIT and PRITSemantic proximity
Select a neighboring publication to make it the new centre.